System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Systematic Review Meta-Analysis Review Ppublish

PubMed: 40614167 DOI: 10.1002/cncy.70031

Diagnostic performance of SHOX2 and RASSF1A gene methylation assays in malignant pleural effusion: A systematic review and meta-analysis.

Cancer Cytopathol 133(8):e70031

Authors: Mohamed Smail Aissani, Kyrillos Mahrous Gerges, Ahmed Msherghi, Hajer Farrara, Dawood Alatefi, Imane Chenfouh, Arwi Omar Kara, Maram Abuajamieh, Ghada Kareem, Mohammed Benhammou, Mohamed E Ali, Max Wintermark, Muhammed Elhadi

Affiliations

  • Faculty of Medicine, University Blida 01, Blida, Algeria. Ibrahime Tirichine Public Hospital, Blida, Algeria.
  • Faculty of Medicine, Sohag University, Sohag, Egypt.
  • The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Graduate School of Public Health and Health Policy, City University of New York, New York, New York, USA.
  • University of Jordan, Amman, Jordan.
  • Faculty of Medicine and Pharmacy, Oujda, Oujda-Angad, Morocco.
  • Faculty of Medicine, University of Benghazi, Benghazi, Libya.
  • Cairo University School of Medicine, Cairo, Egypt.
  • Department of Medicine, Faculty of Medicine, Al-Qadisiyah University, Diwaniyah, Iraq.
  • Faculty of Medicine, University of Oran 1 Ahmed Ben Bella, Oran, Algeria.
  • Crestwood Healthcare, LP, Huntsville, Alabama, USA.
  • College of Medicine, Korea University, Seoul, South Korea.

Abstract

BACKGROUND

Malignant pleural effusion (MPE) is a common complication of advanced malignancies, requiring differentiation from benign pleural effusion for appropriate management. Cytology and biopsy have limitations, necessitating more sensitive, less invasive diagnostic techniques. The objective of this study was to evaluate the diagnostic accuracy of methylated SHOX2 (short-stature homeobox 2) and RASSF1A (Ras association domain family member 1A) genes in detecting MPE.

METHODS

A systematic review and meta-analysis included studies that compared benign pleural effusion and MPE cohorts using methylation of SHOX2 and RASSF1A genes in pleural fluid as the index test and cytology/histopathology as the reference standard. A random-effects model was used to calculate sensitivity, specificity, predictive values, and diagnostic odds ratios. Subgroup analysis assessed performance in lung-predominant versus nonlung-predominant MPE.

RESULTS

Four studies with a total of 534 participants were included. The pooled sensitivity and specificity were 85% (95% confidence interval [CI], 53%-96%; heterogeneity [I 2] = 0.00%) and 92% (95% CI, 88%-95%; I 2 = 24.8%), respectively. The positive and negative predictive values were 93% (95% CI, 85%-97%; I 2 = 61.5%) and 84% (95% CI, 53%-96%; I 2 = 0.00%), respectively. The diagnostic odds ratio was 22.78 (95% CI, 11.00-47.17; I 2 = 25.8%). Subgroup analysis showed a slight decrease in sensitivity (70%; 95% CI, 64%-76%; I 2 = 0.00%) and specificity (91%; 95% CI, 86%-94%; I 2 = 26.1%) when excluding the study with a lung cancer-predominant population.

CONCLUSIONS

The combined analysis of SHOX2 and RASSF1A methylation demonstrated promising diagnostic accuracy for MPE detection, outperforming cytology. This less invasive method could reduce reliance on more invasive procedures, although further research is needed to confirm its efficacy across diverse populations and cancer types.

MeSH

Genes, Lung, Pleural Effusion, Neoplasms, Cell Biology, Odds Ratio, Pleural Effusion, Malignant, Cytology

Cited by